Skip to main content
Journal ArticleOPEN ACCESS

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models

  • He L
  • Thomas L
  • Testa J
  • et al.
Journal for ImmunoTherapy of Cancer (2013) 1(Suppl 1) P76
DOI: 10.1186/2051-1426-1-s1-p76
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

He, L.-Z., Thomas, L. J., Testa, J., Weidlick, J., Sisson, C., Hammond, R., … Keler, T. (2013). Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models. Journal for ImmunoTherapy of Cancer, 1(Suppl 1), P76. https://doi.org/10.1186/2051-1426-1-s1-p76

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free